chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10/29/22 spouse noticed red rash on lower half of scalp, which continues to the day I am reporting this on 11/15/22. In retrospect, I think the rash appeared at least by 10/22/22 and maybe earlier based on memories of periodic itching. I saw a primary care nurse practitioner on 11/10/22 who prescribed ketoconazole shampoo which I started using daily on 11/11/22. On 11/10 or 11/11/22 I developed angular cheilitis which I've treated with ketoconazole ointment that I had on hand. I got a flu shot on the same day as the COVID booster, but I don't know what flu shot it was so I can't add it to this form.
Received first dose Pfizer Covid 19 Vaccine and after that developed Covid.; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program . A 73-year-old female patient started to receive first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EJ6789), dose 1 via an unspecified route of administration on 11Mar2021 (age at the vaccination 73-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications was not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced the caller states her husband tested positive for covid/the caller then tested for covid and also tested positive. On 17Mar2021, received first dose pfizer covid 19 vaccine and after that developed covid on 17Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive. The caller then tested for Covid and also tested positive. The outcome of events was Unknown. Follow-up attempts are possible. Information on Lot/Batch number was available.
Sore, achy muscles, chills, feverish, fatigue, area where injection was given was red, hard and about 2-3" wide.  These symptoms lasted all day.  On day 2, I experienced a few chills, and less muscle soreness.  Arm was still red and sore. Fatigue has lessened but still there.
No adverse reaction, wrong age group COVID vaccine administered as patient was 14 years old at time of administration and needed 12+ COVID vaccine.
Patient fainted 10 minutes after dose was administered. Hypotensive, sweating, slowed breathing, tingling in hands. BP 86/49 10 minutes after administration. BP eventually came up to 114/80 later and patient went home after being evaluated by EMS.
Patient was improperly screened prior to receiving vaccine and was vaccinated 8 days earlier than recommended date; No adverse reaction, but this was considered an medical administration error event.
Chills and lethargy on day 10 after last checking.  Went to bed early. Ok today
Unable to use left arm.  Lost feeling and control of arm.  Same arm as injection of pneumonia and influenza vaccines.  Went to hospital, it was a stroke.  Still has little control or feeling in fingers of left hand.
Pt vaccinated with DTP developed fever 103-104, swelling, redness, a knot, & tenderness at injection site.
This case was reported by a physician via call center representative and described the occurrence of injection site inflammation in a female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site inflammation, injection site swelling, injection site warmth, pain, tiredness, feeling unwell and influenza-like symptoms. On an unknown date, the outcome of the injection site inflammation, injection site swelling, injection site warmth, pain, tiredness, feeling unwell and influenza-like symptoms were recovered/resolved. The reporter considered the injection site inflammation, injection site swelling, injeqction site warmth, pain and tiredness to be related to SHINGRIX. It was unknown if the reporter considered the feeling unwell and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had no concomitant medications available to provide during the call. In 2018, the patient received SHINGRIX in the unknown arm. The reporter did not know exactly what date the patient received the first dose in the series of SHINGRIX or exact dosing details for the administration which occurred at an unknown pharmacy location. The reporter also did not know how soon after receiving the vaccination that the symptoms started. The patient called the reporter on 7th May 2018, and told her that the symptoms started 2 weeks prior to the telephone call and that the symptoms had lasted for five to ten days. The patient reported that the injection site reaction was described as the injection site area of the unknown arm's being inflamed, swollen, and warm to the touch. The patient also did not feel good, described as having had flu-like symptoms of being tired and achy. The call was transferred to the GSK Medical Information regarding her inquiry of whether or not this patient should have a second dose in the series, no further doses, or perhaps a half of a dose. The reporter was the responsible physician and grants permission to be contacted.
Large, itchy, red rash at injection site. started 1 week after receiving vaccination. lasted ~24 hours.
looks like shingles, it hurts her nerves; a very uncomfortable pain in all her left side; looks like shingles, it hurts her nerves; overall rash all around the upper thigh, the front and back and her butt, has pain in it; pain up and down her leg and her back; pain up and down her leg and her back; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (pain up and down her leg and her back), BACK PAIN (pain up and down her leg and her back), NEURALGIA (looks like shingles, it hurts her nerves), DISCOMFORT (a very uncomfortable pain in all her left side) and HERPES ZOSTER (looks like shingles, it hurts her nerves) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus, Kidney infection NOS, Blood pressure high (Improvement, changed medication) and Drug allergy. Concomitant products included AMLODIPINE and OLMESARTAN for Blood pressure, GLIMEPIRIDE for Diabetes, ALLOPURINOL for Gout, PANTOPRAZOLE for Stomach ache, METOPROLOL SUCCINATE, PREDNISONE and FUROSEMIDE for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain up and down her leg and her back), BACK PAIN (pain up and down her leg and her back) and RASH (overall rash all around the upper thigh, the front and back and her butt, has pain in it). On an unknown date, the patient experienced NEURALGIA (looks like shingles, it hurts her nerves), DISCOMFORT (a very uncomfortable pain in all her left side) and HERPES ZOSTER (looks like shingles, it hurts her nerves). At the time of the report, PAIN IN EXTREMITY (pain up and down her leg and her back) had not resolved and BACK PAIN (pain up and down her leg and her back), NEURALGIA (looks like shingles, it hurts her nerves), DISCOMFORT (a very uncomfortable pain in all her left side), HERPES ZOSTER (looks like shingles, it hurts her nerves) and RASH (overall rash all around the upper thigh, the front and back and her butt, has pain in it) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medication included torisemide. The patient received unspecified medication for pain up and down her leg and her back.   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Reporter details, patient demographics, medical history, concomitant medications and event information updated
Mom reports site is red, swollen, and hot to touch. Advised TYLENOL and cold compress.
PATIENT FELL AND HIT HIS HEAD ON THE FLOOR  APPROXIMATELY 10 MINUTES  AFTER INJECTION, CALLED 911 IMMEDIATELY. PATIENT WAS UNCONCIOUS FOR ABOUT A MINUTE, THEN WOKE UP.  PARAMEDICS  ARRIVESD AND ATTEND TO HIM, THEN TOOK HIM TO HOSPITAL.
did not receive the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not receive the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant drug information were given.
This spontaneous report was received from a physician referring to a 21 months old patient of unknown gender. No information about the patient's medical history, concurrent conditions and conocmitant medications was reported. On 16-AUG-2017, the patient was vaccinated with an improperly stored dose of VAQTA injection, lot # N008823, expiry date 26-MAY-2018 (dose, route of administration and site of the vaccination were not specified) for prophylaxis. The administered dose of VAQTA underwent a temperature excursion. The lowest temperature was 32 Fahrenheit degrees and the higher was 54 Fhrenheit degrees for 70 hours. Data logger was not involved.  No adverse effects were reported. There was no product quality complaint involved. This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-1709USA012770: US-009507513-1709USA012767: US-009507513-1709USA007325: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA012764: US-009507513-1709USA012766: US-009507513-1709USA012768:
At approximately 416 pm the patient had received 4 vaccines and after the last vaccine the nurse noted the patient became pale, dizzy, and weak. He started leaning toward the left side of the stretcher. Patient's father and the nurse called his name and he responded. The nurse notified the Physician and she came in to the room to assess the patient. Physician ordered Epinephrine 0.3 ml which was given SQ at 424pm. Then she ordered BENADRYL 25 mg IM which was given at 426. IV line, 22 gauge was placed to Left Ae with NS hung at a rate of 60ml/hr at 432pm. Vial signs were as follows: 90/62, 98.20, and pulse ox 99%. Patient states that he was feeling better and denies any dizziness. Physician called hospital ED to inform them she was send patient to the ED. She then called 911 to transport the patient. EMS arrived and patient was stable at the time and report VS - 109/78, 96.18, and pulse ox 99%. Patient was transported to hospital ED and he was stable at that time. RN.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies were not reported. The patient's concomitant medications included Diluent Mrk Inj which was used for the reconstitution of VARIVAX. On an unknown date the patient was vaccinated with improperly stored VARIVAX (dose, units and frequency not reported) (lot # N030410 and expiration date: 30-OCT-2019) subcutaneously. The administered VARIVAX was stored at a temperature from -14 degree Celsius (C) to -10 C (-11.2) for 24 hours as recorded by data logger. There was no previous temperature excursion for the VARIVAX. No adverse effects were reported. No product quality complaint was involved.
Shots admin to left anterior thigh on 11/26/08: DTAP & MMR.  Mother called office on 11/28/2008 @ 8:30 am to report left leg swelling and warmth.  Mother reports "can't even see her knee".  Instructed by this RN to see MD.  Pt.  c/o discomfort all day 11/27/08.  Attempted to contact patient on return call 12/2/08.
About 30 minutes after getting the first shot of Pfizer vaccines, the left side of my body started to feel like getting swollen.  Left half of my face started feeling swollen and tingling - like when your dental anesthesia was wearing off, and my left arm feeling swollen.  I checked my left hand and my face on the mirror to see if they were really swollen, but they looked normal.  I think it was more of the neurological effect.  I can't remember if my left leg was also impacted.  I think about 30 minutes or so, it started get better so I didn't go to see a doctor.  About an hour after the shot, I think it was pretty much gone.  Now, I may be too self conscious, but I feel like something wrong /weird with the left side of my body/face, but that may be my anxiety tricking me.
heart murmur; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "heart problems" (unspecified if ongoing), notes: in the past. The patient took concomitant medications. The following information was reported: CARDIAC MURMUR (non-serious), outcome "unknown", described as "heart murmur". Additional information: Caller mentioned she saw an advertisements of the new Moderna COVID-19 vaccine for new variants, but the advertisements mentioned that it could cause heart inflammation and inflammation lining of the heart. She wanted to know if the Pfizer 2023-2024 formulation also had this side effect. She mentioned she wanted to know because in the past she already experienced heart problems and wants to know whether or not to get the vaccine. Upon learning that the Pfizer COVID-19 Vaccine does have reports of myocarditis and pericarditis, she mentioned she did experienced a heart murmur after having 3 previous Pfizer COVID-19 Vaccine doses last year and the year before. She mentioned she experienced this murmur after previous doses, but she never thought it could be related to the vaccine as she changed her treating physician. However, she never had any problem and the only thing she's done different was getting the vaccine. She mentioned she does take a low dose of blood pressure medication, but she had been taking it before and didn't change anything in what she does, and she has the same diet. She didn't report it because she never thought it could be related. Caller mentioned she was scared of the side effects and had to balance what is worse if the side effects or COVID-19, mentioning she was specially  scared of the blood clots and the heart inflammation. She stated she was concerned on this information as she has a Thanksgiving dinner next week and doesn't want to risk it, as many of her friends have used Moderna and have gotten very sick. She mentioned she still wears a mask and people look ugly at her and proceeded to mention that she lives in where people are ignorant and many didn't even get the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300382095 same patient/product/events;
Pt given varivax vaccine on 2/21/96 and now, 4 years later, has developed varicella on 11/6/00.
Swelling of arm occurred 7/4/2014. and then 36hrs later angioedema. Severe swelling of lips (2 hrs and worsening) given shot of epinephrine and Prednisolone. Sent home with Prednisolone for 5 days, Epipen and  Benadryl.
metal taste in mouth - very prominent; loss of taste and smell; loss of taste and smell; back pain on the right and in the front of stomach; in the front of stomach; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (metal taste in mouth - very prominent), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell), BACK PAIN (back pain on the right and in the front of stomach) and ABDOMINAL PAIN UPPER (in the front of stomach) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 immunisation.     The patient's past medical history included Injection (she received the wrong type of steroid; cortisone instead of Euflexxa) on 10-Feb-2021. Concomitant products included CORTISONE and HYALURONATE SODIUM (EUFLEXXA) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DYSGEUSIA (metal taste in mouth - very prominent), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell), BACK PAIN (back pain on the right and in the front of stomach) and ABDOMINAL PAIN UPPER (in the front of stomach). At the time of the report, DYSGEUSIA (metal taste in mouth - very prominent), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell), BACK PAIN (back pain on the right and in the front of stomach) and ABDOMINAL PAIN UPPER (in the front of stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided by the reporter.
patient presented to emergency dept on 10/27/21 for right flank pain and discharge from drain patient was admitted for further management of abdominal pain patient was found to be covid-19 positive on 10/29/21 patient did not require treatment for symptoms associated with covid-19 infection. patient was discharged to home on 10/31/21
Swollen lymph nodes in neck, arm, and chest. Sore Throat, fatigue, headache. Lymph nodes swollen on right side after one week of injection. Bilateral swelling of lymph nodes by day nine.
My fingers started tingling about an hour after the vaccine then my feet started tingling.  It subsided about 18 hours after.  Now my fingers are tingling intermittently and my toes and feet are now pretty constantly tingling/pins and needles and are going numb often.
Headache; Joint pain/ache; Fatigue; Chills; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 30Apr2021 at 15:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) started on unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 09Apr2021 at 15:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01May2021, the patient experienced headache, joint pain/ache, chills, fatigue (but not debilitatingly so). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 01May2021, patient underwent lab test which included nasal swab for SARS CoV-2 test and the result was negative. The clinical outcome of the event headache, joint pain/ache, chills, fatigue were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
gout flare in right foot in evening  of vaccine -- took colchicine in am - waiting for improvement
Redness and increased temperature of the entire left leg following DTaP and IPV injections in the same thigh. Lasted for 4-5 mins and resolved spontaneously.
Site injection pain, chills, low grade fever, muscle aches for 24 hours.  Treated with over the counter Tylenol and fluids.  This was the booster shot and surprised at reaction given that I had COVID the end of January 2021.
Employee received the Pfizer Covid vaccine.  She was feeling nauseous.   Soon after she ate, she vomited.  She refuse to go to the Emergency room.  She felt better to complete her shift.
a little bit of soreness in the area of injection; This is a spontaneous report from a non-contactable consumer (patient) received via a sales representative. A 27-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced a little bit of soreness in the area of injection on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received Hep b vaccine at left deltoid on 04/11/2002.  She developed an erythematous rash and swelling of left arm, mild rash on right arm and throat itching.
Area warm to the touch and erythemic over right deltoid where vaccine was given.  Erythema lasted approx. 1 day, area still warm to touch on 3rd day post vaccination.
pt recv vax 1993 & that same day pt exp hives & itching;p/ 5 to 7 months pt recovered from exp;
MYALGIA, LOCAL ERYTHEMA/SORENESS, MIGRAINE, FATIGUE, INSOMNIA Narrative:  ERYTHEMA/SORENESS AT INJECTION SITE, INABILITY TO SLEEP; SYMPTOMS WERE ONGOING AT THE TIME OF REPORTING ON 1/29/21 (ABSENT FROM WORK 1/29/21)  Other Relevant History:
Chills, body aches, headache. moderate. lasted approximately 24 hours . no fever
Pain seems to come from injection site, then into the shoulder joint and sometimes travels to the elbow and forearm; Pain in the left arm; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EP- EN6202) via an unspecified route of administration on the left arm on 03Mar2021 at 14:30 (at the age of 67-year-old) as a single dose for Covid-19 immunisation. The patient medical history included hypertension. The patient was allergic to amoxicillin and NSAIDS. The patient concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 12Mar2021, the patient experienced pain in the left arm which seemed to have come from injection site, then moved into the shoulder joint and sometimes travelled to the elbow and forearm. This pain began in the late afternoon and continued through the night but it was absent most of the day. The patient did not receive any treatment for the reported events. The clinical outcome for the events pain in the left arm, pain seems to come from injection site, then into the shoulder joint and sometimes travels to the elbow and forearm were not recovered.   No follow-up attempts are needed. No further information is expected.